Please login to the form below

Not currently logged in

Merck & Co’s Jürgen Polifka joins Cardiome

Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess

Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and marketing Europe.

Polifka was most recently regional marketing leader hospital care at Merck for a portfolio of products, including atrial fibrillation treatment Brinavess (vernakalant), which Cardiome is due to assume commercialisation responsibility for in Europe.

In total, Polifka spent more than 16 years at Merck, serving in several senior roles, such as product manager, marketing and sales manager, director hospital and specialty products and brand leader. During this time, he covered both infectious disease and cardiovascular care at different stages.

"We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer.

"His personal experience with Brinavess at MSD and deep understanding of the European hospital and cardiovascular markets will be invaluable as Cardiome assumes commercialisation responsibility for Brinavess in Europe."

9th April 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...